N-acetyl glucosamine as gastroprotective agent

摘要

This invention relates to the novel use of N-acetyl glucosamine (NAG) to treat gastritis and to maintain the integrity and normal function of the upper gastrointestinal (GI) tract. A method of treating gastrointestinal mucous membrane disorder in the gastrointestinal tract of a human being comprising feeding the human being a therapeutic amount of N-acetyl glucosamine on a regular periodic basis.